Long Noncoding RNAs: Clarity or Confusion?
Because They Are Such Elusive Prey, lncRNAs Have Yet to Emerge as Therapeutic Targets
Markets Expand for Single-Use Bioreactors
Biobags Offer Advantages Over Fixed-Tank Systems
The Challenges of Harmonizing Biomarker Data
Why Trial Success Depends on It
Top 10 Wall Street Losers of 2016
These Companies Lost the Most in a Down Year for Biopharma Stocks
For full access to this article login to GEN Select now.
Pushing Toward a $1,000 Genome
Stepwise Technological Evolution Will Continue, But Disruptive Spurts Are Also Forecast
- Recent reports in Science illustrate the range of applications enabled by sequencing technologies pioneered by Roche (www.roche.com) and 454 Life Sciences (www.454.com), now a Roche company. In one study (Science 2007; 317:1927-1930), researchers performed whole genome shotgun sequencing of mitochondrial DNA extracted from the ancient Siberian mammoth to examine ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.